Le Lézard
Classified in: Health, Business
Subject: TNM

BelHealth Completes Asset Sale of General Genetics Corp.


FORT LAUDERDALE, Fla., Sept. 9, 2021 /PRNewswire/ -- September 9, 2021?BelHealth Investment Partners, LLC ("BelHealth") is pleased to announce that it has completed the sale of assets of the international division of General Genetics Corporation (GGC), a provider of relationship and clinical genetic testing services, to Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) is a diversified molecular diagnostics company ("GTG"). The transaction was structured in a combination of cash and stock of GTG. 

"We are pleased to see this transaction come to fruition," said Inder Tallur.

Founded in 2013, GGC, managed its non-US based direct-to-consumer (DTC) genetic testing business consisting of trademarks, websites, and a strong network of brand agents via two offices based in Malta and Australia. BelHealth acquired GGC to target the rapidly evolving genomics sector by acquiring three genetic testing laboratories in the US combined with the international direct-to-consumer business to complement its laboratory services. In May 2015, GGC sold the laboratory business and focused solely on the international business and its primary brand EasyDNA.

"We are pleased to see this transaction come to fruition" said Inder Tallur, Managing Partner, BelHealth. "We believe this acquisition will enable GTG to integrate EasyDNA into its overall "health and wellness" testing platform and position itself for future growth. As shareholders, we look forward to a successful partnership with GTG."

About BelHealth Investment Partners
BelHealth Investment Partners is a healthcare private equity firm focused on U.S. based lower middle market companies. BelHealth has a unique combination of investing, executive management and entrepreneurial experience. BelHealth acquires majority positions in entrepreneur-owned companies that it believes would benefit from its extensive operating and private equity investment expertise. The firm typically invests $20-$50 million per platform company. BelHealth is currently investing from Fund II, a $350 million fund.

Media Contact:

BelHealth:
Inder Tallur: (917) 975-6604, [email protected]

SOURCE BelHealth Investment Partners


These press releases may also interest you

at 08:35
Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue
Vistagen , a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced positive results from a Phase 2A pilot study of PH15, an...

at 08:34
Canopy Positions for Growth with Appointment of Susanne Clark as President
Canopy Life Sciences ("Canopy"), a leading provider of clinical to commercial solutions to the life sciences industry, is delighted to announce the appointment of Susanne Clark as President. With over 25 years of experience in the life sciences...

at 08:34
Innovative Medical Products & Curexo Inc. Announce Strategic OUS Distribution Partnership
Innovative Medical Products, Inc. (IMP) and Curexo Inc. are pleased to announce a global strategic distribution partnership combining Curexo's artificial joint surgical robot, CUVIS-joint, with IMP's industry-leading De Mayo D2® Knee Positioner....

at 08:34
Dr. James B. Chen Brings Best-in-Class Total Joint Replacement to DISC Surgery Center at Newport Beach
DISC Sports & Spine Center ("DISC") has enlisted Dr. James B. Chen to bring a best-in-class total joint replacement program to its renowned DISC Surgery Center at Newport Beach. The highly skilled orthopedic surgeon is an Orange County native and...

at 08:32
Malaria No More Commends the U.S. President's Malaria Initiative on Progress in the Face of Increasing Challenges
As we celebrate World Malaria Day 2024, Malaria No More commends the incredible progress made by the U.S. President's Malaria Initiative (PMI), as outlined in its newly released 18th Annual Report to Congress....

at 08:32
Innovative Eyewear, Inc. Partners with New Look Vision Group to Provide Smart Eyewear in Canada
Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") , the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, is pleased to announce their Lucyd smart frames are now available from NewLook.ca and...

More news about Health...


News published on and distributed by: